))
The Phage Therapy Today is the pod dedicated to leaders in the phage therapy industry. We bring you insights into current advancements and challenges in this exciting sector from academia, financial, regulatory, manufacturing and entrepreneurial perspectives. Each episode features accomplished guests serving various roles in developing our bacteriophage-evolved community. If you are a believer in the future shaped by phage therapy and want to share you exciting work with our community, email ...
…
continue reading
1
Understanding Phage Therapy from a General Public's Perspective with Dr. Christopher Shaffer
42:34
42:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:34
Happy Tuesday Everyone and Welcome back to the latest episode of Phage Therapy Today! Phage science is awesome, the business is growing, and the numbers on paper are looking great. But along with this excitement, we must realize the end goal is to save lives and improve clinical outcomes. The truth is phage therapy is still very far from accessible…
…
continue reading
1
Global Funding Opportunity at INCATE with Dr. Mercedes Gonzalez and Kinzbio CEO Dr. Gregorio Iraola
32:34
32:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
32:34
Welcome back to Phage Therapy Today! As phage therapy is becoming global, so are funding opportunities. In this week's episode, our guests, Dr. Mercedes Gonzalez from Incubator for Antibacterial Therapies in Europe (INCATE) and Dr. Gregorio Iraola, at Kinzbio sat down with us to talk about these funding opportunities and how startup companies can b…
…
continue reading
1
Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL
29:34
29:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:34
Standardizing the phage therapy industry through processes like clinical trails is the way to go . One of the fundamental steps to broader use of phage therapy and successful therapy is producing phages following Good Manufacturing Practices (GMP) and JAFRAL is the leader in this field. In today's show we sit down with JAFRAL's founder and CEO Dr. …
…
continue reading
1
The Ultimate Precision Medicine Story with tolka.ai CEO Johan Wikstroem
32:10
32:10
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
32:10
As a serial entrepreneur, Johan Wikstroem founded a phage therapy company recently with one goal in mind, to treat his own Mycobacteroides abscessus infection and more people with conditions like himself. Listen in to this week's "Phage Therapy Today" and find out more about how our guest transitioned from tech to biotech and overcoming the hurdles…
…
continue reading
1
A Phage Therapy Cardiology Patient Case Study and Followup with Dr. Gina Suh: Director at Mayo Clinic's Phage Therapy Program
30:08
30:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
30:08
In this week's Phage Therapy Today, we get back together with Dr. Gina Suh to learn about her recent progress and experience in the application of phage therapy at Mayo Clinic. If you are interested in learning about the first case of phage therapy in treatment of a cardiology case, leading to a successful heart transplant after the clearing of hea…
…
continue reading
1
Bacteriophage Drug Development and Regulatory Affairs with Dr. Carrie-Lynn Langlais Furr, CEO and Co-founder at Bacteriophage & Drug Development Consultants (BDDC)
44:15
44:15
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
44:15
As more phage-based and phage-derived products and therapies emerge, swift decisions and strategies in drug development, designing clinical trials and approaching regulatory agencies come in handy. In this week's Phage Therapy Today, we sit down with Dr. Carrie-Lynn Langlais Furr, coming from a solid bacteriophage science background and coming with…
…
continue reading
1
The 'Citizen Phage Library' with Dr. Ben Temperton
31:59
31:59
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
31:59
Happy Tuesday everyone and welcome back to phage therapy today! Listen in to today's episode, we sit down with Dr. Ben Temperton, Professor at University of Exeter and founder of Citizen Phage Library. Learn about Dr. Temperton's journey and his vision for how citizen phage library can help shape the phage therapy landscape. Let's give it a listen!…
…
continue reading
1
Bacteriophage Engineering for Clinical and Agricultural Applications with Cytophage Technologies Inc. CEO Dr. Steven Theriault
48:35
48:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
48:35
Phage killing bacteria is cool but understanding phages and engineering their molecular biology is just another level cool. In today's 'Phage Therapy Today' podcast, we sit down with Dr. Steven Theriault, a proud Canadian, a scientist, and an entrepreneur from Cytophage Tehnologies Inc. Listen to the episode and learn about how he is building and e…
…
continue reading
1
Phage Genome Annotation with Rime Bioinformatics CEO Dr. Antoine Culot
27:35
27:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
27:35
Phage genome annotation is a critical component in phage therapy to help us understand the functions of phage genes and ensure efficacy of phages. In this week's phage therapy today, we sit down with the founder and CEO at Rime Bioinformatics Dr. Antoine Culot to discuss the current challenges, regulations and opportunities in using bioinformatic t…
…
continue reading
1
"The Genesis Story" and Progress in Phage Therapy with Dr. Steffanie Strathdee at UCSD IPATH
38:33
38:33
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
38:33
In today's show, we sit down with Dr. Steffanie Strathdee, whose family story of saving her husband's life from a life-threatening superbug infection using phage therapy really inspired a lot of the most important works today in the phage therapy field. Listen to today's episode to learn about her story. Among her many roles, as the director of the…
…
continue reading
1
Using bacteriophages to bring back antimicrobials sensitivity in Acinetobacter baumannii with Dr. Jeremy Barr
43:10
43:10
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
43:10
How do bacteriophages shape bacterial fitness and how does it lead to the resensitiization of antimicrobials? In today's show, we are delighted to have Dr. Jeremy Barr from Monash University to talk about his research and his recent republication on Nature Microbiology "Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobi…
…
continue reading
1
A Phage Therapy Case Study with Dr. Gina Suh: Infectious Diseases Specialist at Mayo Clinic
42:57
42:57
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:57
There have been several quite famous successful cases of using phage therapy for treatment. One of those cases was carried out at Mayo Clinic by the founder and director of Mayo Clinic’s Phage Therapy Program Dr. Gina Suh. Listen to our conversation on this story and the consideration along the process. We dig deep into how physicians are perceivin…
…
continue reading
1
Entrepreneurship in Phage Therapy and Fighting Cholera, Poverty, Social Injustice and so much more with Dr. Minmin Yen @PhagePro
42:59
42:59
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:59
Welcome back to Phage Therapy Today and in this episode, we have Dr. Minmin Yen from PhagePro joining us to discuss her and her team's recent progress on bringing preventive phage therapy product to fight Cholera, an acute, diarrheal illness that's often associated with poverty, poor infrastructure and social injustice. Listen to her journey of bri…
…
continue reading
1
Investment Strategies in Phage Therapy with Dr. Richard Alm at CARB-X
42:35
42:35
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:35
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator(CARB-X) is one global nonprofit partnership that manages a large portfolio of early stage companies to do the job as described by its name. In this episode, we are happy to have its chief scientist Dr. Richard Alm to help us paint a broad picture of the antimicrobial landscape an…
…
continue reading
1
Interacting with the FDA: A Dynamic Process, an interview with Dr. Austen Terwilliger @BMC TailorLabs
38:41
38:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
38:41
Dr. Austen Terwilliger is the director of operations at BMC TailorLabs, overseeing the cooperation between phage providers, physicians and regulatory agencies. In this conversation, we sit down and understand the dynamic nature in these processes and let's take a minute to think about how we can setup standards to better help patients. Check out Dr…
…
continue reading
1
Product Development and Product Prospects with Adaptive Phage Therapeutics CEO Greg Merril
38:00
38:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
38:00
In business for just 5 years, Adaptive Phage Therapeutics has no doubt made tremendous progress and built itself as one of the most competitive leader in our industry. Learn about the founding story and the milestones achieved at APT from its CEO Greg Merril, and most importantly, the direction Greg envisions where we are going. Attached here is th…
…
continue reading
1
Phage Exploration and Phage Therapy @BCM TailorLabs with Dr. Sabrina Green: Phages, from Bench to Bedside
44:41
44:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
44:41
We may think the magic in phage therapy is in the treatment. That is true. But to make this magic happen, collaborative team efforts is necessary to together prepare the stage and get ready for the show. Dr. Sabrina Green is currently the director of R&D at Baylor college of medicine Tailorlabs 'https://www.bcm.edu/research/research-centers/tailor'…
…
continue reading
1
Phage/Phage Therapy 101 with Dr. Irene Chen: All You Need to Know
22:43
22:43
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
22:43
Dr. Irene Chen is currently a faculty member at UCLA working on building the next generation phage therapy platform. If you are new to this field and want to catch up a bit, this is the right episode for you. On this episode, we'll talk about what phages are, what phage therapy is, what's the current state of art and much more. Besides the amazing …
…
continue reading
Phage therapy today is the go to podcast to learn about current achievement and progress in phage therapy. We've gathered incredible guests joining us to share their works and ideas using phage therapy to fight this antimicrobial war. We do this together, and together we can do this.
…
continue reading
